Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew L Mason

Showing results (71-80 of 110) with videos related to

Pageof 11
Sort By:
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinomaNorman M Kneteman, José Oberholzer, Mohammed Al Saghier, et al.
Microbiome|January 5, 2019
Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseasesHeather Armstrong, Misagh Alipour, Rosica Valcheva, et al.
Inflammatory Bowel Diseases|May 5, 2015
Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteriaWeiwei Wang, Juan Jovel, Brendan Halloran, et al.
Journal of Hepatology|March 25, 2024
Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort studyChristina G Plagiannakos, Gideon M Hirschfield, Ellina Lytvyak, et al.
The New England Journal of Medicine|May 22, 2009
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variantsGideon M Hirschfield, Xiangdong Liu, Chun Xu, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitisSurain B Roberts, Gideon M Hirschfield, Lawrence J Worobetz, et al.
Journal of Hepatology|April 14, 2019
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitisMaren H Harms, Henk R van Buuren, Christophe Corpechot, et al.
The American Journal of Gastroenterology|August 14, 2024
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External ControlsKris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
The American Journal of Gastroenterology|December 2, 2024
Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External ControlsKris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
Gut|January 9, 2015
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international studyPalak J Trivedi, Willem J Lammers, Henk R van Buuren, et al.
Pageof 11

Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
Sirolimus-based immunosuppression for liver transplantation in the presence of extended criteria for hepatocellular carcinomaNorman M Kneteman, José Oberholzer, Mohammed Al Saghier, et al.
Microbiome|January 5, 2019
Host immunoglobulin G selectively identifies pathobionts in pediatric inflammatory bowel diseasesHeather Armstrong, Misagh Alipour, Rosica Valcheva, et al.
Inflammatory Bowel Diseases|May 5, 2015
Metagenomic analysis of microbiome in colon tissue from subjects with inflammatory bowel diseases reveals interplay of viruses and bacteriaWeiwei Wang, Juan Jovel, Brendan Halloran, et al.
Journal of Hepatology|March 25, 2024
Treatment response and clinical event-free survival in autoimmune hepatitis: A Canadian multicentre cohort studyChristina G Plagiannakos, Gideon M Hirschfield, Ellina Lytvyak, et al.
The New England Journal of Medicine|May 22, 2009
Primary biliary cirrhosis associated with HLA, IL12A, and IL12RB2 variantsGideon M Hirschfield, Xiangdong Liu, Chun Xu, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Ethnicity, disease severity, and survival in Canadian patients with primary biliary cholangitisSurain B Roberts, Gideon M Hirschfield, Lawrence J Worobetz, et al.
Journal of Hepatology|April 14, 2019
Ursodeoxycholic acid therapy and liver transplant-free survival in patients with primary biliary cholangitisMaren H Harms, Henk R van Buuren, Christophe Corpechot, et al.
The American Journal of Gastroenterology|August 14, 2024
COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External ControlsKris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
The American Journal of Gastroenterology|December 2, 2024
Correction to COBALT: A Confirmatory Trial of Obeticholic Acid in Primary Biliary Cholangitis With Placebo and External ControlsKris V Kowdley, Gideon M Hirschfield, Charles Coombs, et al.
Gut|January 9, 2015
Stratification of hepatocellular carcinoma risk in primary biliary cirrhosis: a multicentre international studyPalak J Trivedi, Willem J Lammers, Henk R van Buuren, et al.
Pageof 11